Diagnosis

WHO Prequalifies First HCV Self-Test to Expand Global Access and Elimination Efforts

The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test, OraQuick HCV self-test, manufactured by OraSure Technologies. This self-test, an extension…

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women's Hospital & Teaching Hospital of Harvard Medical School

Patient Management Guidelines

Articles

APOE4’s Paradoxical Role: Increased COVID-19 Severity but Protection in HCV Liver Disease

Hepatitis C virus (HCV) and COVID-19 both affect the liver and cardiovascular systems, with the APOE4 allele playing a complex...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Global HCV in Dialysis: 24.3% Prevalence Demands Urgent Action

A systematic review and meta-analysis involving 634 studies across 392,160 patients revealed a global hepatitis C virus (HCV) prevalence of...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

HCV-Related CLD Deaths Surpass HBV: Global Efforts Needed to Curb Rising Mortality by 2030

An analysis of data from the Global Burden of Diseases Study (2019) revealed that hepatitis C virus (HCV)-related chronic liver...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Global HCV Trends in Women: Rising Incidence Demands Targeted Interventions

Researchers of a recent study explored global trends in acute hepatitis C (AHC) and HCV-related cirrhosis among women of reproductive...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Direct-Acting Antivirals Achieve High Cure Rates

Hepatitis C virus (HCV) is a significant public health issue, with an increasing seroprevalence of anti-HCV antibodies from 2.3% to...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

US Lagging in HCV Elimination: White House Proposes Plan

Hepatitis C virus (HCV) elimination is a critical global health objective, yet the US is falling short of the World...